Mifalei Zichron Menachen Jerusalem for Medicine & Benevolence

Analysis

Mifalei Zichron Menachen Jerusalem for Medicine & Benevolence is a registered charity in United States, based in Israel. It received its IRS tax-exemption ruling in February 2008, 18 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3).

In the financial year ending December 2023, Mifalei Zichron Menachen Jerusalem for Medicine & Benevolence reported income of $2.9m and spending of $3.3m, spending 111% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $3.8m to $2.9m (-22%), an average of -6.2% a year. The sharpest change came in the year to December 2021, when income rose by 54%. Over the whole period it spent 105% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Mifalei Zichron Menachen Jerusalem for Medicine & Benevolence sits at the 75th percentile: it is larger than about 75% of them. Against every charity in United States with reported income it ranks in the 89th percentile. Charities of a similar size with the same main cause include Harm Reduction Therapy Center ($2.9m), Casa de Amma Inc ($2.9m) and Treatment Advocacy Center ($2.9m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 82% and program service revenue 16% of the total. Compensation of current officers, directors and key employees was $1.4m (44% of expenses). At year end it held assets of $6.1m against liabilities of $191k, net assets of $5.9m.